Neonates exposed to SARS-CoV-2 in utero at higher risk of respiratory distress, study finds

Researchers found that neonates born to mothers with SARS-CoV-2 infection face an increased risk of respiratory distress, potentially due to an inflammatory response triggered by prenatal exposure.

J&J’s major depressive disorder drug hits endpoints in Phase 3 trial

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

May 30, 2024

Unveiling brain sex differences with AI

A new study by Stanford Medicine investigators unveils a new artificial intelligence model that was more than 90% successful at determining whether scans of brain

February 20, 2024

Exact Sciences’ cancer blood test achieves 51% sensitivity in prospective trial

Dive Brief: Exact Sciences’ multi-cancer early detection (MCED) blood test has achieved 50.9% sensitivity at 98.5% specificity across 21 cancer types, the company said Monday

April 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.